Toggle Main Menu Toggle Search

Open Access padlockePrints

Carbonyl reductase 1: a novel regulator of blood pressure in Down Syndrome

Lookup NU author(s): Professor Brian WalkerORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

Approximately one in every 800 children is born with the severe aneuploid condition of Down syndrome (DS), a trisomy of chromosome 21. Low blood pressure (hypotension) is a common condition associated with DS and can have a significant impact on exercise tolerance and quality of life. Little is known about the factors driving this hypotensive phenotype, therefore therapeutic interventions are limited. Carbonyl reductase 1 (CBR1) is an enzyme contributing to the metabolism of prostaglandins, glucocorticoids, reactive oxygen species and neurotransmitters, encoded by a gene (CBR1) positioned on chromosome 21 with the potential to affect blood pressure. Utilising telemetric blood pressure measurement of genetically modified mice, we tested the hypothesis that CBR1 influences blood pressure and that its overexpression contributes to hypotension in DS by evaluating possible contributing mechanisms in vitro. In a mouse model of DS (Ts65Dn), which exhibits hypotension, CBR1 activity was increased and pharmacological inhibition of CBR1 ed to increased blood pressure. Mice heterozygous null for Cbr1 had reduced CBR1 enzyme activity and elevated blood pressure. Further experiments indicate that the underlying mechanisms include alterations in both sympathetic tone and prostaglandin metabolism. We conclude that CBR1 activity contributes to blood pressure homeostasis and inhibition of CBR1 may present a novel therapeutic opportunity to correct symptomatic hypotension in DS.


Publication metadata

Author(s): Malbon AJ, Czopek A, Beekman AM, Goddard ZR, Boyle A, Ivy JR, Stewart K, Walker BR, Dhaun N, Bailey MA, Morgan RA

Publication type: Article

Publication status: Published

Journal: Bioscience Reports

Year: 2025

Volume: 45

Issue: 2

Print publication date: 26/02/2025

Online publication date: 27/01/2025

Acceptance date: 23/01/2025

Date deposited: 24/01/2025

ISSN (print): 0144-8463

ISSN (electronic): 1573-4935

Publisher: Portland Press Ltd.

URL: https://doi.org/10.1042/BSR20241636

DOI: 10.1042/BSR20241636

Data Access Statement: The data included in this study are available from the corresponding authors upon reasonable request.


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
206587/Z/17/Z
Wellcome Senior Investigator Award

Share